BICO
Cellink AB
Application Filed: 2021-05-05
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90692202 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Margarita Wallach, Esq. |
| Attorney Name | Margarita Wallach, Esq. |
| Attorney Docket Number | 128026 |
Timeline
| 2021-05-05 | Application Filed |
| 2021-05-08 | Location: NEW APPLICATION PROCESSING |
| 2021-05-08 | Status: Live/Pending |
| 2021-05-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Cellink AB |
| Entity Statement | aktiebolag (ab) |
| Address | Arvid Wallgrens backe 20 Göteborg SE 41346 |
| Legal Entity Type | |
| Legal Entity State | SE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 7 |
| U.S. Codes: | 013,019,021,023,024,031,034,035 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 36 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Biologically compatible polymers, namely, hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research; Biologically compatible materials, namely, hydrogels used to create structures and scaffolds used in the manufacture of living tissue; Biological tissue specimens for use in scientific research; Cellulose nanofibril based biological preparations for use in 3d bioprinting of tissues and organs; Proteins in raw material form for scientific and medical research; Chemicals used in industry and science; nucleic acids, peptides and proteins; immobilised chemical compounds; in particular nucleic acids, peptides and proteins; collections of chemical compounds for industrial and scientific purposes, in particular immobilised chemical compounds for industrial and scientific purposes, arrays of chemical compounds, in particular nucleic acids, peptides and proteins; arrays of collections of chemical compounds, in particular collections of chemical compounds on a carrier; compounds manufactured with the aid of immobilised chemical compounds, collections of chemical compounds or arrays of chemical compounds, or collections of chemical compounds, in particular immobilised on a carrier; the aforesaid chemicals and chemical compounds used in particular in the fields of pharmacy, foodstuffs, plant protection, cosmetics, diagnostics and basic biochemical and medical research. Monoclonal antibodies for scientific use; tagged antibodies for laboratory use; tagged antibodies for scientific use; monoclonal antibodies for scientific purposes; monoclonal antibodies for diagnostic use (other than medical); biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; reagents for use in the development of hybridoma antibodies (other than for medical or veterinary purposes); reagents for use in the development of monoclonal antibodies (other than for medical or veterinary purposes); proteins for detecting antibodies (other than for medical use); proteins for binding antibodies (other than for medical use); immunological antibodies, other than for medical use; monoclonal antibodies for industrial use; monoclonal antibody reagents, other than for medical use; stem cells for research purposes; stem cells for scientific purposes; stem cells for research or scientific purposes; stem cells other than for medical or veterinary purposes; collagen based ingredients for cosmetic preparations; hydrogel polymer coatings; lactic acid polymers; aqueous linear polymer gels; polymer coatings (other than paints); photo curable compositions comprising polymers; chemicals for use in polymerisations; polymer beads for use in manufacturing; polymer beads for use in manufacture; polymers of glucose for industrial use; water soluble polymers for industrial use; polymer based compounds for use in manufacture; amino acrylic polymers for use in manufacture; polymers for use as reference standards in science; polymeric chemicals for use in the cosmetic industry; polymers for use in the analysis of nucleic acids; chemicals for use in performing nucleic acid polymerase chain reactions (other than medical and veterinary); proteins for use in science; proteins for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; enzymes (other than for medical use) for detecting protein fractions; enzymes (other than for medical use) for labelling protein fractions; enzymes (other than for medical use) for labelling proteins; enzymes (other than for medical use) for measuring proteins; proteins for use in recombinant dna technology (other than for medical use); biochemicals namely, polypeptides for in vitro research use; diagnostic reagents for in-vitro use (other than medical); biochemicals for in vitro and in vivo scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; reagents for in-vitro laboratory use (other than for medical or veterinary purposes); diagnostic reagents for scientific use; diagnostic preparations for scientific purposes; diagnostic preparations for scientific use; diagnostic preparations used in science; chemical products for diagnostic use (scientific); in-vivo diagnostic reagents scientific use; diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; reagents for use in diagnostic tests (other than for medical or veterinary purposes); chemical reagents for use in diagnostic tests, other than for medical or veterinary use; media for cell culture for use in the biotechnological industry; media for cell culture for use in non-medical research laboratories; biological preparation for use in cell cultures other than for medical or veterinary use; cultures of cell media (other than for medical or veterinary use); engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Chemicals for use in industry and science; chemical substances, chemical materials, chemical preparations, chemical reagents and natural elements, in particular for use in laboratories or in the biotechnological industry or for non-medical scientific and research purposes; cell growth media and cell growth reagents, in particular for use in laboratories or in the biotechnological industry or for non-medical scientific and research purposes; cell culture media and cell culture reagents, in particular for use in laboratories or in the biotechnological industry or for non-medical scientific and research purposes; biological preparations for use in industry and science; biological reagents, in particular for use in laboratories or in the biotechnological industry or for non-medical scientific and research purposes; biological tissue cultures, in particular for use in laboratories or in the biotechnological industry or for non-medical scientific and research purposes; cultures of microorganisms, in particular for use in laboratories or in the biotechnological industry or for non-medical scientific and research purposes; with all of the aforesaid goods other than for medical or veterinary purposes. Cells, tissue models in the nature of biological tissue cultures, cell growth media, and biomaterials for use in biological, biomedical, and life sciences research. Chemical products for use in lithography; lithographic chemicals; photoresists for lithography; resists for lithography; liquid photosensitive resin for the fabrication of three-dimensional models |
| GS0401 | Custom 3D printing services; Creation of customised three-dimensional shaped parts using rapid prototyping equipment; custom 3D printing, namely, 3D bioprinting; Bioprinting being 3D printing for others; Renting of 3D printers; custom synthesis of chemicals used in industry and science, in particular nucleic acids, peptides and proteins, chemical compounds for industrial and scientific purposes, in particular immobilised chemical compounds for industrial and scientific purposes, arrays of chemical compounds, in particular nucleic acids, peptides and proteins, arrays of collections of chemical compounds, in particular collections of chemical compounds on a carrier, compounds made with the aid of immobilised chemical compounds; immobilisation of arrays of chemical compounds for others, in particular nucleic acids, peptides and proteins; immobilisation of arrays of collections of chemical compounds for others, in particular collections of chemical compounds on a carrier; custom 3D reproduction services; lithographic material treatment, namely, lithographic printing; treatment of materials by laser beam, namely, microstructuring and nanostructuring; lithographic printing; Treatment of materials, in particular laser engraving, engraving, galvanisation, gilding, silver-plating, chromium plating, nickel plating; treatment of materials, namely, conversion, shaping and coating from organic and inorganic starting materials into and onto components and structures with dimensions up to the micrometer and nanometer scale, namely, custom bioprinting; laser-lithographic treatment of materials involving the chemical and/or physical modification of materials, namely, laser-lithographic printing; custom fabrication for others of machines for automated assembly and packaging of rapid tests; all aforementioned services unrelated to the dental field and to the dental surgical field |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2021-05-08 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-08-06 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-10-04 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-10-20 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-10-20 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-10-20 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-04-20 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2022-04-25 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-04-28 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-04-28 | 10 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-04-29 | 11 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-05-18 | 12 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-06-07 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-06-07 | 14 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-08-02 | 15 NOAM E:E-Mail |
| TEAS POST PUBLICATION AMENDMENT RECEIVED | 2022-11-01 | 16 EPPA I:Incoming Correspondence |
| TEAS DELETE 1(B) BASIS RECEIVED | 2022-11-11 | 17 D1BR I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-11-23 | 18 AITU A:Allowance for Publication |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-11-23 | 19 CHAN I:Incoming Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2022-11-11 | 20 IUCN S: |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2022-11-23 | 21 DP1B I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2023-01-03 | 22 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-01-03 | 23 NRCC E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 